Contribution of α2-adrenoceptors and Y1 neuropeptide Y receptors to the blunting of sympathetic vasoconstriction induced by systemic hypoxia in the rat

Journal of Physiology

Volumn 582, Issue 3, 2007, Pages 1349-1359

  Coney, Andrew M ^a   Marshall, Janice M ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; HYDROGEN; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y1 RECEPTOR; OXYGEN; YOHIMBINE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y Y1 RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR; UNCLASSIFIED DRUG;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CONTROLLED STUDY; EVOKED RESPONSE; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SKELETAL MUSCLE; SYMPATHETIC TONE; VASCULAR RESISTANCE; VASOCONSTRICTION; WISTAR RAT; ANIMAL; ANOXIA; DRUG EFFECT; ELECTROSTIMULATION; HINDLIMB; PATHOPHYSIOLOGY; PHYSIOLOGY; FEMORAL VASCULAR RESISTANCE; HINDLIMB MUSCLE; PROTEIN FUNCTION;

ANIMALS; ANOXIA; ELECTRIC STIMULATION; HINDLIMB; MALE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, NEUROPEPTIDE Y; VASOCONSTRICTION; YOHIMBINE;

EID: 34547114233     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.132563     Document Type: Article

References (63)

1. Bartlett IS & Marshall JM (2002). Analysis of the effects of graded levels of hypoxia on noradrenaline-evoked contraction in the rat iliac artery in vitro. Exp Physiol 87, 171-184.
2. Bischoff A, Freund A & Michel MC (1997). The Y-1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y. Naunyn-Schmiedebergs Arch Pharmacol 356, 635-640.
3. 2adrenoceptor mediated vasoconstrictor response in normotensive subjects and in patients with essential hypertension. Clin Res 31, A843.
4. 1 receptors. J Physiol 514, 151-162.
5. Coney AM, Bishay M & Marshall JM (2004). Influence of endogenous nitric oxide on sympathetic vasoconstriction in normoxia, acute and chronic hypoxia in the rat. J Physiol 555, 793-804.
6. Coney AM & Marshall JM (2003). Contribution of adenosine to the depression of sympathetically evoked vasoconstriction induced by systemic hypoxia in the rat. J Physiol 549, 613-623.
7. Dinenno FA, Eisenach JH, Dietz NM & Joyner MJ (2002). Post-junctional α-adrenoceptors and basal limb vascular tone in healthy men. J Physiol 540, 1103-1110.
8. Dinenno FA, Joyner MJ & Halliwill JR (2003). Failure of systemic hypoxia to blunt α-adrenergic vasoconstriction in human forearm. J Physiol 549, 985-994.
9. Ebeigbe AB (1982). Influence of hypoxia on contraction and calcium uptake in rabbit aorta. Experimentia 38, 935-937.
10. Edmunds NJ & Marshall JM (2001a). Vasodilatation, oxygen delivery and oxygen consumption in rat hindlimb during systemic hypoxia: Roles of nitric oxide. J Physiol 532, 251-259.
11. Edmunds NJ & Marshall JM (2001 b). Oxygen delivery and oxygen consumption in rat hindlimb during systemic hypoxia: Role of adenosine. J Physiol 536, 927-935.
12. Ekelund U & Erlinge D (1997). In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle. Br J Pharmacol 120, 387-392.
13. 1-adrenergic receptors in the canine femoral bed. Hypertension 6, 915-925.
14. Faber JE (1988). In situ analysis of α-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ Res 62, 37-50.
15. 2 inhibits calcium channel activity in arterial smooth muscle cells. Am J Physiol Heart Circ Physiol 271, H2290-H2299.
16. 2-adrenoceptor involvement in the vascular responses to neuronally released and exogenous noradrenaline in the hindlimb of the dog and cat. Eur J Pharmacol 84, 189-198.
17. Hansen J, Sander M, Hald CF, Victor RG & Thomas GD (2000). Metabolic modulation of sympathetic vasoconstriction in human skeletal muscle: role of tissue hypoxia. J Physiol 527, 387-396.
18. Heistad DD & Wheeler RC (1970). Effect of acute hypoxia on vascular responsiveness in man. J Clin Invest 49, 1252-1263.
19. Hudson S, Johnson CD, Coney AM & Marshall JM (2002). Changes in sympathetic nerve activity recorded from skeletal muscle arteries of the anaesthetized rat during graded levels of systemic hypoxia. J Physiol 544.P, 28P.
20. 1-receptor control of basal hindlimb vascular tone. Am J Physiol Regul Integr Comp Physiol 287, R228-R233.
21. 2-adrenoceptors in man. Circ Res 54, 447-452.
22. 2-adrenoceptor in human blood vessels - interactions with exogenous and endogenous catecholamines. Eur J Clin Invest 17, 174-181.
23. Johnson CD, Coney AM & Marshall JM (2001). Roles of norepinephrine and ATP in sympathetically evoked vasoconstriction in rat tail and hindlimb in vivo. Am J Physiol Heart Circ Physiol 281, H2432-H2440.
24. Johnson CD & Gilbey MP (1996). On the dominant rhythm in the discharges of single postganglionic sympathetic neurons innervating the rat tail artery. J Physiol 497, 241-259.
25. Joshua IG (1991). Neuropeptide Y-induced constriction in small resistance vessels of skeletal muscle. Peptides 12, 37-41.
26. Kennedy C, Saville VL & Burnstock G (1986). The contributions of noradrenaline and ATP to the responses of the rabbit ear artery to sympathetic nerve stimulation depend on the parameters of stimulation. Eur J Pharmacol 122, 291-300.
27. 2 -Adrenoceptor-mediated vasoconstriction of arteries. Clin Pharmacol Ther 34, 565-569.
28. Lundberg JM, Franco-Cereceda A, Lou YP, Modin A & Pernow J (1994). Differential release of classical transmitters and peptides. Adv Second Messenger Phosphoprotein Res 29, 223-234.
29. 1 receptor antagonist BIBP3226. Br J Pharmacol 116, 2971-2982.
30. Macefield VG, Wallin BG & Vallbo AB (1994). The discharge behaviour of single vasoconstrictor motoneurons in human muscle nerves. J Physiol 481, 799-809.
31. 2 -adrenoceptor constriction of rat skeletal-muscle microvessels. Circ Res 69, 165-173.
32. Marshall JM (1994). Peripheral chemoreceptors and cardiovascular regulation. Physiol Rev 74, 543-594.
33. Marshall JM & Metcalfe JD (1988). Analysis of the cardiovascular changes induced in the rat by graded levels of systemic hypoxia. J Physiol 407, 385-403.
34. + channels, potassium and muscle vasodilatation in the rat in systemic hypoxia. J Physiol 472, 1-9.
35. 2 adrenoceptors in the saphenous arterial bed. J Pharmacol Exp Ther 246, 249-254.
36. Mian R & Marshall JM (1991). The roles of catecholamines in responses evoked in arterioles and venules of rat skeletal muscle by systemic hypoxia. J Physiol 436, 499-510.
37. Michel MC & Rascher W (1995). Neuropeptide Y - a possible role in hypertension. J Hypertens 13, 385-395.
38. Modin A, Pernow J & Lundberg JM (1991). Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur J Pharmacol 203, 165-171.
39. Morris JL & Gibbins IL (1992). Co-transmission and neuromodulation. In Autonomic Neuroeffector Mechanisms, ed. Burnstock G & Hoyle CHV, pp. 33-119. Harwood, Chur, Switzerland.
40. Muldowney SM & Faber JE (1991). Preservation of venular but not arteriolar smooth muscle α-adrenoceptor sensitivity during reduced blood flow. Circ Res 69, 1215-1225.
41. 2-adrenoceptors on microvascular smooth muscle during sympathetic nerve stimulation. Circ Res 68, 232-244.
42. Pearce WJ, Ashwal S, Long DM & Cuevas J (1992). Hypoxia inhibits calcium influx in rabbit basilar and carotid arteries. Am J Physiol Heart Circ Physiol 262, H106-H113.
43. Pernow J & Lundberg JM (1986). Neuropeptide-Y constricts human skeletal muscle arteries via a nifedipine-sensitive mechanism independent of extracellular calcium. Acta Physiol Scand 128, 655-656.
44. Pernow J, Ohlen A, Hokfelt T, Nilsson O & Lundberg JM (1987). Neuropeptide Y - presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man. Regul Pept 19, 313-324.
45. Pernow J, Schwieler J, Kahan T, Hjemdhal P, Oberle J, Wallin BG & Lundberg JM (1989). Influence of sympathetic nerve discharge pattern on norepinephrine and neuropeptide Y-release. Am J Physiol Heart Circ Physiol 257, H866-H872.
46. Qureshi NU, Dayao EK, Shirali S, Zukowska-Grojec Z & Hauser GJ (1998). Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock. Regul Pept 75-76, 215-220.
47. Racchi H, Irarrazabal MJ, Howard M, Moran S, Zalaquett R & Huidobro-Toro JP (1999). Adenosine 5′-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein. Br J Pharmacol 126, 1175-1185.
48. Ralevic V & Burnstock G (1990). Postjunctional synergism of noradrenaline and adenosine 5′-triphosphate in the mesenteric arterial bed of the rat. Eur J Pharmacol 175, 291-299.
49. Ray CJ, Abbas MR, Coney AM & Marshall JM (2002). Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: In vivo and in vitro studies. J Physiol 544, 195-209.
50. Rowell LB & Seals DR (1990). Sympathetic activity during graded central hypovolemia in hypoxemic humans. Am J Physiol Heart Circ Physiol 259, H1197-H1206.
51. Ruffolo RR, Nichols AJ, Stadel JM & Hieble JP (1991). Structure and function of α-adrenoceptors. Pharmacol Rev 43, 475-505.
52. Sjöblom-Widfeldt N, Gustafsson H & Nilsson H (1990). Transmitter characteristics from small mesenteric arteries in the rat. Acta Physiol Scand 138, 203-212.
53. Skinner MR & Marshall JM (1996). Studies on the roles of ATP, adenosine and nitric oxide in mediating muscle vasodilatation induced in the rat by acute systemic hypoxia. J Physiol 495, 553-560.
54. 2 -adrenoceptors. Naunyn-Schmiedebergs Arch Pharmacol 348, 593-600.
55. 2-mediated adrenergic vasoconstriction in human vessels. Eur J Clin Pharmacol 34, 407-410.
56. 1 -adrenoceptor constriction by acidosis and hypoxia in vitro. Am J Physiol Heart Circ Physiol 268, H2068-H2076.
57. Teranishi Y, Tsuru H, Shimomura H, Amano T & Matsubayashi H (2000). Compensatory vasoconstrictor effects of sodium pentobarbital on the hindquarters of conscious normotensive control and lumbar-sympathectomized Wistar rats. Auton Neurosci 82, 130-136.
58. 2-adrenergic vasoconstriction during contraction of glycolytic, not oxidative, rat hindlimb muscle. Am J Physiol Heart Circ Physiol 266, H920-H929.
59. Thomas GD, Hansen J & Victor RG (1997). ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Clin Invest 99, 2602-2609.
60. Tomlinson C, Coney AM & Marshall JM (2005). Do prostanoids modulate sympathetically-evoked vasoconstriction in skeletal muscle in normoxia or hypoxia. FASEB J 19, A713.
61. Weisbrod CJ, Minson CT, Joyner MJ & Halliwill JR (2001). Effects of regional phentolamine on hypoxic vasodilatation in healthy humans. J Physiol 537, 613-621.
62. 1-receptor contribute to blood pressure control in the spontaneously hypertensive rat? J Hypertens 15, 19-27.
63. Zukowska-Grojec Z & Vaz AC (1988). Role of neuropeptide Y (NPY) in cardiovascular responses to stress. Synapse 2, 293-298.